U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07326059) titled 'Safety and Outcomes of MUSE Stem Cell Therapy in Individuals With Traumatic Brain Injury' on Dec. 08, 2025.
Brief Summary: This prospective observational study evaluates the safety profile and patient-reported outcomes associated with MUSE (Multilineage-differentiating Stress-Enduring) stem cell therapy in individuals aged 6 to 75 with chronic traumatic brain injury (TBI). Participants independently elect to receive MUSE cell treatment through international clinical programs, and this study aims to capture real-world evidence on the potential therapeutic effects and risks of this emerging regenerative approach.
The study does not ad...